Business Description
Lexicon Pharmaceuticals is a Texas-based drug company that discovers and brings to market treatments for serious medical conditions, including heart failure, diabetes, obesity, and nerve pain. Its main products and pipeline are built around a small number of oral medicines, most notably sotagliflozin, which is already approved under the brand name INPEFA to help reduce life-threatening cardiovascular events in adults with heart failure or type 2 diabetes. The company works alongside partners Viatris and Bristol-Myers Squibb to support the development and distribution of its treatments.
